INTERNATIONAL PATENT: SKYMAB BIOTHERAPEUTICS FILES APPLICATION FOR "ANTIBODY-DRUG CONJUGATE COMPRISING AN ANTI-ETB-R ANTIBODY AND USES THEREOF"

GENEVA, June 10 -- SKYMAB BIOTHERAPEUTICS (8 rue de Balzac37000 Tours) filed a patent application (PCT/EP2024/083650) for "ANTIBODY-DRUG CONJUGATE COMPRISING AN ANTI-ETB-R ANTIBODY AND USES THEREOF" on Nov 26, 2024. With publication no. WO/2025/114295, the details related to the patent application was published on Jun 05, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MERABET, Manel (7 A boulevard de la Petite Rente13011 Marseille), MOULINE, Caroline (12 Route de l'Audeverdiere37510 Savonnieres), ALLARD, Bertrand (5332 Rue de VerdunMontreal, Quebec H4H1K4), NGUYEN, Andree Aiphi (35 boulevar...